加强澳大利亚书面药品信息的提供:药剂师、全科医生及消费者对障碍因素与促进因素的看法。
Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators.
作者信息
Hamrosi Kim K, Raynor David K, Aslani Parisa
机构信息
Faculty of Pharmacy, The University of Sydney, Pharmacy & Bank Building A15, Sydney NSW 2006, Australia.
出版信息
BMC Health Serv Res. 2014 Apr 23;14:183. doi: 10.1186/1472-6963-14-183.
BACKGROUND
Written medicine information can play an important role in educating consumers about their medicines. In Australia, standardised, comprehensive written information known as Consumer Medicine Information (CMI) is available for all prescription medicines. CMI is reportedly under-utilised by general practitioners (GPs) and community pharmacists in consultations, despite consumer desire for medicine information. This study aimed to determine consumers', GPs' and community pharmacists' preferences for CMI provision and identify barriers and facilitators to its use.
METHOD
Structured questionnaires were developed and administered to a national sample of Australian consumers (phone survey), community pharmacists and GPs (postal surveys) surrounding utilisation of CMI. Descriptive and comparative analyses were conducted.
RESULTS
Half of consumers surveyed wanted to receive CMI for their prescription medicine, with spoken information preferable to written medicine information for many consumers and healthcare professionals. GPs and pharmacists remained a preferred source of medicine information for consumers, although package inserts were appealing to many among all three cohorts. Overall pharmacists were the preferred provider of CMI primarily due to their medicine expertise, accessibility and perceived availability. GPs preferred CMI dissemination through both the GP and pharmacist. Some consumers preferred GPs as the provider of medicines information because of their knowledge of the patients' medicines and/or medical history, regularity of seeing the patient and good relationship with the patient. Common barriers to CMI provision cited included: time constraints, CMI length and perceptions that patients are not interested in receiving CMI. Facilitators to enhance provision included: strategies to increase consumer awareness, longer consultation times and counseling appointments, and improvements to pharmacy software technology and workflow.
CONCLUSION
Medicine information is important to consumers, whether as spoken, written or a combination of both. A tailored approach is needed to ascertain individual patient preference for delivery and scope of medicine information desired so that appropriate information is provided. The barriers of time and perceived attitudes of healthcare practitioners present challenges which may be overcome through changes to workplace practices, adoption of identified facilitators, and education about the positive benefits of CMI as a tool to engage and empower patients.
背景
书面药品信息在向消费者普及药品知识方面可发挥重要作用。在澳大利亚,所有处方药都有标准化、全面的书面信息,即消费者药品信息(CMI)。尽管消费者渴望获取药品信息,但据报道,全科医生(GP)和社区药剂师在诊疗过程中对CMI的利用率较低。本研究旨在确定消费者、全科医生和社区药剂师对提供CMI的偏好,并找出其使用的障碍和促进因素。
方法
围绕CMI的使用情况,编制结构化问卷并对澳大利亚全国范围内的消费者样本(电话调查)、社区药剂师和全科医生(邮寄调查)进行调查。进行描述性和比较性分析。
结果
接受调查的消费者中有一半希望收到所开处方药的CMI,对于许多消费者和医疗保健专业人员来说,口头信息比书面药品信息更受欢迎。全科医生和药剂师仍然是消费者获取药品信息的首选来源,不过药品说明书对所有三个群体中的许多人都有吸引力。总体而言,药剂师是CMI的首选提供者,主要是因为他们的药学专业知识、可及性以及人们认为他们随时可提供信息。全科医生倾向于通过全科医生和药剂师两者来传播CMI。一些消费者更倾向于让全科医生作为药品信息提供者,因为他们了解患者的用药情况和/或病史、定期看诊患者以及与患者关系良好。所提及的提供CMI的常见障碍包括:时间限制、CMI篇幅以及认为患者对接收CMI不感兴趣。促进提供CMI的因素包括:提高消费者意识的策略、更长的诊疗时间和咨询预约,以及药房软件技术和工作流程的改进。
结论
药品信息对消费者很重要,无论是口头的、书面的还是两者结合的形式。需要采用一种量身定制的方法来确定个体患者对药品信息传递方式和所需范围的偏好,以便提供适当的信息。时间以及医疗保健从业者的感知态度等障碍带来了挑战,不过可以通过改变工作场所的做法、采用已确定的促进因素以及开展关于CMI作为让患者参与并赋予其权力的工具所具有的积极益处的教育来克服这些挑战。
相似文献
Pharm World Sci. 2008-12
J Clin Pharm Ther. 2010-10-19
Patient Prefer Adherence. 2015-3-19
引用本文的文献
Int J Pharm Pract. 2020-12
Prim Health Care Res Dev. 2019-6-20
J Multidiscip Healthc. 2020-3-19
Br J Clin Pharmacol. 2019-5-7
BMJ Open. 2019-1-17
BMC Health Serv Res. 2018-3-12
本文引用的文献
Res Social Adm Pharm. 2010-5-27
Ann Pharmacother. 2009-3-24
Ann Pharmacother. 2007-6